Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326732-25-000053
Filing Date
2025-05-07
Accepted
2025-05-07 16:09:38
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20250331.htm   iXBRL 10-Q 1015096
2 EX-10.1 xncr-20250331xexx101.htm EX-10.1 47201
3 EX-31.1 xncr-20250331xexx311.htm EX-31.1 10229
4 EX-31.2 xncr-20250331xexx312.htm EX-31.2 10075
5 EX-32.1 xncr-20250331xexx321.htm EX-32.1 6325
  Complete submission text file 0001326732-25-000053.txt   6945833

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20250331.xsd EX-101.SCH 47949
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20250331_cal.xml EX-101.CAL 85488
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20250331_def.xml EX-101.DEF 234349
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20250331_lab.xml EX-101.LAB 644497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20250331_pre.xml EX-101.PRE 462765
82 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20250331_htm.xml XML 1030731
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 25921410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)